Kidney cancer, Renal cell cancer
Results
Phase 3
This trial was looking at the combination of standard treatment and a vaccine called TroVax for advanced kidney cancer (renal cell cancer).
Recruitment start: 19 February 2007
Recruitment end: 11 April 2008
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor R Hawkins
Experimental Cancer Medicine Centre (ECMC)
National Institute for Health Research Cancer Research Network (NCRN)
Oxford Biomedica
Last reviewed: 17 August 2016
CRUK internal database number: 899